Effect of multipeak spectral modeling of fat for liver iron and fat quantification: Correlation of biopsy with MR imaging results

Radiology

Volumn 265, Issue 1, 2012, Pages 133-142

  Kühn, Jens Peter ^a,b   Hernando, Diego ^b   Muñoz Del Rio, Alejandro ^b,c   Evert, Matthias ^a   Kannengiesser, Stephan ^d   Völzke, Henry ^a   Mensel, Birger ^a   Puls, Ralf ^a   Hosten, Norbert ^a   Reeder, Scott B ^b,c  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MR Applications Development   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

AREA UNDER CURVE; BIOPSY; FATTY LIVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IRON; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 84866605548     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112520     Document Type: Article

References (47)

1. Bosserhoff A, Hellerbrand C. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. Dig Dis 2011;29(4):377-383.
2. Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44(4):865-873. (Pubitemid 46489550)
3. Schindhelm RK, Diamant M, Heine RJ. Nonalcoholic fatty liver disease and cardiovascular disease risk. Curr Diab Rep 2007;7(3):181-187. (Pubitemid 46951915)
4. Scorletti E, Calder PC, Byrne CD. Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 2011;40(3):332-343.
5. Kew MC. Hepatic iron overload and hepatocellular carcinoma. Cancer Lett 2009;286(1):38-43.
6. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 2011;55(4):920-932.
7. Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999;31(3):421-429. (Pubitemid 29408723)
8. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114(2):311-318. (Pubitemid 28093538)
9. Moirand R, Mortaji AM, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349(9045):95-97. (Pubitemid 27023427)
10. Powell EE, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005;129(6):1937-1943. (Pubitemid 41772971)
11. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344(7):495-500. (Pubitemid 32164902)
12. Copel L, Sosna J, Kruskal JB, Kane RA. Ultrasound- guided percutaneous liver biopsy: indications, risks, and technique. Surg Technol Int 2003;11:154-160.
13. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128(7):1898-1906. (Pubitemid 40824701)
14. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979;139(6):667-669. (Pubitemid 10097795)
15. Fishbein MH, Mogren C, Gleason T, Stevens WR. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2006;42(1):83-88. (Pubitemid 43061015)
16. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007;189(6):W320-W323.
17. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239(1):105-112.
18. Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 2010;18(3):359-381, ix.
19. Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011;258(3):767-775.
20. Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011;258(3):749-759.
21. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multi-echo gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009;251(1):67-76.
22. Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 2010;18(3):337-357, ix.
23. Hines CD, Yu H, Shimakawa A, et al. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010;254(1):119-128.
24. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007;58(2):354-364. (Pubitemid 47267653)
25. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2*estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008;60(5):1122-1134.
26. Yu H, McKenzie CA, Shimakawa A, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2*estimation. J Magn Reson Imaging 2007;26(4):1153-1161. (Pubitemid 47548182)
27. Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008;26(3):347-359.
28. Ghugre NR, Wood JC. Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med 2011;65(3):837-847.
29. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2*mapping accurately estimates hepatic iron concentration in transfusion- dependent thalassemia and sickle cell disease patients. Blood 2005;106(4):1460-1465. (Pubitemid 41129616)
30. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22(23):2171-2179. (Pubitemid 33139463)
31. Hines CD, Yokoo T, Bydder M, et al. Optimization of flip angle to allow tradeoffs in T1 bias and SNR performance for fat quantification [abstr]. In: Proceedings of the Eighteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2010; ##.
32. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009;29(6):1332-1339.
33. Hines CD, Frydrychowicz A, Hamilton G, et al. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011;33(4):873-881.
34. Kühn JP, Evert M, Friedrich N, et al. Non-invasive quantification of hepatic fat content using three-echo Dixon magnetic resonance imaging with correction for T2*relaxation effects. Invest Radiol 2011;46(12):783-789.
35. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-2474. (Pubitemid 29420675)
36. Schwenzer NF, Machann J, Haap MM, et al. T2*relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin. Invest Radiol 2008;43(12):854-860.
37. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193(2):533-538.
38. Gandon Y, Olivié D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363(9406):357-362. (Pubitemid 38169542)
39. Virtanen JM, Komu ME, Parkkola RK. Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2*methods. Magn Reson Imaging 2008;26(8):1175-1182.
40. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105(2):855-861. (Pubitemid 40070775)
41. Guyader D, Gandon Y, Robert JY, et al. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 1992;15(3):304-308.
42. Chezmar JL, Nelson RC, Malko JA, Bernardino ME. Hepatic iron overload: diagnosis and quantification by noninvasive imaging. Gastrointest Radiol 1990;15(1):27-31. (Pubitemid 20001102)
43. Hankins JS, McCarville MB, Loeffler RB, et al. R2*magnetic resonance imaging of the liver in patients with iron overload. Blood 2009;113(20):4853-4855.
44. Thomsen C, Wiggers P, Ring-Larsen H, et al. Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn Reson Imaging 1992;10(6):867-879. (Pubitemid 23082019)
45. 1H MR spectrum. NMR Biomed 2011;24(7):784-790.
46. Hernando D, Liang ZP, Kellman P. Chemical shift-based water/fat separation: a comparison of signal models. Magn Reson Med 2010;64(3):811-822.
47. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230(3):652-659. (Pubitemid 38252858)